Drug Type Small molecule drug |
Synonyms Ribavirin/hydroxychloroquine |
Target |
Mechanism IMPDH inhibitors(Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors), RNAP inhibitors(Bacterial DNA-directed RNA polymerase inhibitors), mRNA guanylyltransferase inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H12N4O5 |
InChIKeyIWUCXVSUMQZMFG-AFCXAGJDSA-N |
CAS Registry36791-04-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Phase 3 | - | - | |
Hepatitis C | Phase 3 | FR | - |
Not Applicable | 15 | kwqnzgzeqb(ggxwbmwtjg) = pmywhndzgd mrxvxgemta (tfrglvpxfu ) | - | 01 Jan 2016 | |||
kwqnzgzeqb(ggxwbmwtjg) = xxkgleuwye mrxvxgemta (tfrglvpxfu ) | |||||||
Not Applicable | - | 15 | (vnkxgtbcyb) = uovfipamjw hdofbgbbqb (szvwkbwaik ) | - | 01 Jan 2002 |